Superworth

Zimmer Biomet EV/EBIT ZBH

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2010.

Today, Oct 23, 2026
21.5×
10-year median
28.7×
Against its 10-year history
14th
percentile: 0 is its lowest day, 100 its highest
10-year range
18.0× to 64.2×
Peer median
23.4×

Zimmer Biomet's EV/EBIT is 21.5× as of Oct 23, 2026.

That is below its ten-year median of 28.7×, lower than on 86% of days in the last ten years.

Over that time it ranged from 18.0× in Jan 2026 to 64.2× in Apr 2021.

The median for 10 medical device stocks of a similar size is 23.4×.

EV/EBIT over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far21.5×18.0×23.9×
202518.6×18.1×22.5×
202421.7×21.2×28.7×
202327.3×24.2×36.0×
202230.2×25.0×30.9×
202127.1×26.1×64.2×
202058.5×20.4×61.9×
201937.4×27.3×37.5×
201827.1×26.2×31.9×
201729.1×27.4×34.8×
201631.2×30.2×54.2×
201546.7×15.9×47.2×
201416.2×14.3×16.9×
201315.0×10.5×15.0×
201210.8×8.7×11.4×
20118.6×7.7×11.8×
20109.4×8.8×10.9×

Against its peers

Companies in Medical - Devices nearest Zimmer Biomet's size, closest first, today.

CompanyEV/EBIT
ZBHZimmer Biomet21.5×
DXCMDexCom25.3×
GEHCGE HealthCare Technologies14.7×
EWEdwards Lifesciences23.5×
BSXBoston Scientific18.2×
LIVNLivaNova22.6×
ITGRInteger29.7×
SYKStryker23.4×
MDTMedtronic20.7×
TMDXTransMedics34.7×
ABTAbbott Laboratories28.2×
Peer median23.4×

Where Zimmer Biomet ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Zimmer Biomet

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.